Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2002
07/04/2002WO2001044513A3 Random domain mapping
07/04/2002WO2001042512A3 Normalization controls and duplex probes for quantitative hybridization reactions
07/04/2002WO2001036589A9 Human ex vivo immune system
07/04/2002WO2001035100A9 Binding acceleration techniques for the detection of analytes
07/04/2002WO2001034806A9 Methods and compositions for screening using diphtheria toxin constructs
07/04/2002WO2001032673A9 Sequences encoding human neoplastic marker
07/04/2002WO2000074687A9 Antisense modulation of b7 protein expression
07/04/2002WO2000071729A9 Recombinant hosts suitable for simultaneous saccharification and fermentation
07/04/2002WO2000067037A9 A combined rapid anti-microbial susceptibility assay and microorganism identification system
07/04/2002WO2000022430A9 Neisseria genomic sequences and methods of their use
07/04/2002US20020088018 Transgenic mice containing MAS orphan receptor gene disruptions
07/04/2002US20020088013 CaMK-X1 and its uses
07/04/2002US20020086989 Photoactivatable nucleic acid derivatives
07/04/2002US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders
07/04/2002US20020086985 Fluorescent dye for use in the detection of preferential compounds
07/04/2002US20020086981 Method of isolation of regulated virulence determinants from bacterial pathogens
07/04/2002US20020086975 P2u2 receptor antibodies
07/04/2002US20020086972 Adaptor protein FRS2 and related products and methods
07/04/2002US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy
07/04/2002US20020086845 Rat PTTG polypeptide and method for producing it
07/04/2002US20020086839 Inhibitors of DNA immunostimulatory sequence activity
07/04/2002US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC
07/04/2002US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
07/04/2002US20020086826 Antibodies against ligand for receptor activator of NF-kB
07/04/2002US20020086825 Genes associated with mechanical stress, expression products therefrom, and uses thereof
07/04/2002US20020086823 Nucleic acids, proteins, and antibodies
07/04/2002US20020086822 Nucleic acids, proteins, and antibodies
07/04/2002US20020086821 Nucleic acids, proteins, and antibodies
07/04/2002US20020086811 Nucleic acids, proteins, and antibodies
07/04/2002US20020086443 Magnetic separation of preferential particle in solution; obtain sample, attract particles to preferential zones, immobilize preferential particle
07/04/2002US20020086428 Controlling nucleotide sequence propagaton cells; obtain cells, transform with preferential expression vectors, monitor cell for preferential expression
07/04/2002US20020086424 Biodetectors targeted to specific ligands
07/04/2002US20020086422 Preferential stem cells, for use in the treatment of autoimmune and immunological defects
07/04/2002US20020086417 Apparatus for use in th analysis of nucleotide sequences
07/04/2002US20020086416 Device for use in the detection, separation and analysis of nucleotide sequences
07/04/2002US20020086408 Ubiquitin-like conjugating protein
07/04/2002US20020086405 56638, a novel human neprilysin protease and uses thereof
07/04/2002US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer
07/04/2002US20020086400 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
07/04/2002US20020086399 Method of measurement of protease and thin membranes used for said method
07/04/2002US20020086395 Method for evaluating the ability of a compound to inhibit the protoporphyrinogen oxidase activity
07/04/2002US20020086386 B-catenin assays, and compositions therefrom
07/04/2002US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides
07/04/2002US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
07/04/2002US20020086379 Human membrane-spanning proteins
07/04/2002US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke
07/04/2002US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy
07/04/2002US20020086353 Nucleotide sequences coding polypeptides for use in the treatment of cancer, skin, immunological, nervous system, develpomental and cardiovascular disorders
07/04/2002US20020086343 Diagnosing the intensity of a pain in humans; obtain sample, monitor sample for marker gene expression, correlate marker expression with pain
07/04/2002US20020086342 Detection of enzyme inhibitors; obtain sample, incubate with modulator, monitor sample for dephosphorylation, compare to control
07/04/2002US20020086338 Compound for use in monitoring activities of free radicals
07/04/2002US20020086336 Process for detecting serine/threonine kinase activity
07/04/2002US20020086326 Methods and kits for isolating biological target materials using silica magnetic particles
07/04/2002US20020086325 Microarrays for use in the detection of preferential compounds in sample
07/04/2002US20020086324 Process for high throughput DNA methylation analysis
07/04/2002US20020086323 Splitting preferential nucleotide sequences; obtain nucleotide sequences, incubate with intregrase, incubate with substrate, recover nucleotide sequence products
07/04/2002US20020086322 Microarray-based analysis of polynucleotide sequence variations
07/04/2002US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences
07/04/2002US20020086318 Apparatus for use in the determination of nucleotide sequences
07/04/2002US20020086317 Sequencing preferential nucleotide sequences; obtain nucleotide sequences, insert preferential heavy elements into compound, insert into microscope, monitor base preferential labels, determine nucleotide sequence
07/04/2002US20020086316 Reagents and methods useful for detecting diseases of the prostate
07/04/2002US20020086315 Method of determining a chemotherapeutic regimen based on ERCC1 expression
07/04/2002US20020086313 Application of bioinformatics for direct study of unculturable microorganisms
07/04/2002US20020086312 Screening for modulator of receptor binding activity; obtain cells, incubate with modulator, monitor cell response
07/04/2002US20020086310 Detecting target of microbiocide; obtain nucleotide sequences, insert into vector, induce expression of gene, compare propagation of cells, determine antibiotic resistance
07/04/2002US20020086309 Flat plate nucleotide detection cell for use in the monitoring and screening sample for the presence of peferential nucleotide sequences
07/04/2002US20020086306 Detecting preferential nucleotide sequences in sample; obtain sample containing nucleotide sequences, incubate with primer, amplify, hybridize signal probe, detect signal
07/04/2002US20020086305 Human c-Maf compositions and methods of use thereof
07/04/2002US20020086304 Method of isolation of regulated virulence determinants from bacterial pathogens
07/04/2002US20020086301 Reagents and methods useful for detecting diseases of the prostate
07/04/2002US20020086299 Methods of screening potential translational regulatory elements of messenger RNA
07/04/2002US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein
07/04/2002US20020086294 Device and method for tracking conditions in an assay
07/04/2002US20020086291 Analyzing structural properties of nucleotide sequences; obtain nucleotide sequences, hydrolyze nucleotide sequences, separate and detect nucleotide sequences
07/04/2002US20020086290 Method for determining the prognosis of a patient with a neurological disease
07/04/2002US20020086289 Screening sample for the presence of multiple microorganisms; obtain sample, incubate with multiple probes, monitor hybridization pattern, detect microorganismal nucleotide sequences
07/04/2002US20020086288 Kit for the detection of carcinogenic compounds
07/04/2002US20020086287 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit
07/04/2002US20020086286 Accurate diagnosis of infections; obtain nose secretions, monitor contents, determine type of infection
07/04/2002US20020086284 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection
07/04/2002US20020086282 Methods and compositions for detecting compounds that modulate inflammatory responses
07/04/2002US20020086279 Protein activity screening of clones having DNA from uncultivated microorganisms
07/04/2002US20020086278 Nutrient broth; for use in the propagation and visualization of preferential bacteria
07/04/2002US20020086277 Determination of antibiotic efficacy in treating microbial infection
07/04/2002US20020086034 Compositions and methods for treating viral infections
07/04/2002US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds.
07/04/2002US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/04/2002US20020086016 Diagnostic methods based upon a particular genotype in the Tumor Necrosis Factor (TNF alpha ) gene
07/04/2002US20020086013 Administering an agent that inhibits a component of the VEGF signal transduction pathway; agent decreases a connective tissue growth factor (CTGF) activity in the tissue of the subject.
07/04/2002US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
07/04/2002US20020085998 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and T cells that are specific for cells expressing such polypeptides.
07/04/2002US20020085954 Depositing an inorganic sol-gel permeation layer on a micro-electronic device for molecular biological reactions; can be created with pre-defined porosity, pore size distribution, pore morphology, and surface area.
07/04/2002DE10064689A1 Verfahren zur Bestimmung der Blutzellhämostase Method for determining the Blutzellhämostase
07/04/2002DE10062244A1 Sensor zur Detektion von makromolekularen Biopolymeren, Sensoranordnung, Verfahren zur Detektion von makromolekularen Biopolymeren und Verfahren zum Herstellen eines Sensors zur Detektion von makromolekularen Biopolymeren Sensor for detecting macromolecular biopolymers, sensor arrangement, method for detecting macromolecular biopolymers, and method for manufacturing a sensor for detecting macromolecular biopolymers
07/04/2002DE10037759A1 Screeningverfahren Screening method
07/04/2002CA2847458A1 Defects in periaxin associated with myelinopathies
07/04/2002CA2782510A1 Polypeptides
07/04/2002CA2436777A1 A screening assay for antagonists of human leukocyte receptors
07/04/2002CA2433135A1 Detection of genetic polymorphisms in genes associated with pharmacogenomics
07/04/2002CA2432927A1 Antibacterial treatments